Response to therapy and HLA phenotype
| Comparison . | HLA-A . | HLA-B . | HLA-Cw . | HLA-DR . | HLA-DQ . |
|---|---|---|---|---|---|
| Immunosuppression vs controls | NS | B14 13% vs 8% z = 3.4 N = 305 | NS | DR2 42% vs 28% z = 5.3 N = 281 | NS |
| Comparison . | HLA-A . | HLA-B . | HLA-Cw . | HLA-DR . | HLA-DQ . |
|---|---|---|---|---|---|
| Immunosuppression vs controls | NS | B14 13% vs 8% z = 3.4 N = 305 | NS | DR2 42% vs 28% z = 5.3 N = 281 | NS |
HLA phenotype was analyzed in patients with bone marrow failure treated with immunosuppressive therapy (as indicated in “Patients, materials, and methods”) and compared to the controls. Only alleles that are substantially different from controls are shown.